SHARDACROP

Management reported FY26 as the best year in company history, driven by strong revenue, EBITDA, and PAT. For FY27, management guided for revenue growth of 10-15%, EBITDA margins of 18-20%, and gross margins around 35%. Volume growth is expected around 15%. The company remains debt-free with significant cash reserves (INR 702 Cr as of March 31, 2026) and incurred a CAPEX of INR 505 Cr in FY26. Growth drivers include recovery in the global agrochemical market, ability to pass on raw material price increases, and continuous investment in product registrations (3,011 registrations, 1,004 in pipeline). The company sees significant scope for market share improvement, with continued demand for agrochemicals globally.

Sharda Cropchem Limited announced the schedule of an Analyst / Institutional Investor Meeting on 29th May 2026, from 11:00 AM to 2:00 PM. The meeting, organized by 360 One Capital (B&K) - Trinity India 2026, will be held at Grand Hyatt, Mumbai. Discussions will be based on publicly available information, and no unpublished price sensitive information (UPSI) will be shared.

Sharda Cropchem Limited announced the availability of the audio recording for its conference call with analysts and investors regarding the Q4 FY 2025-26 Audited Financial Results. The call was conducted on Thursday, May 14, 2026, at 01:00 P.M. (IST), and the audio link is accessible on the company's website.

Sharda Cropchem Limited's Board of Directors, at their meeting on May 13, 2026, considered and recommended a final dividend of Rs. 9.00 per equity share of face value Rs. 10.00 each for the financial year 2025-26. This recommendation is subject to the approval of shareholders at the forthcoming Annual General Meeting.

Sharda Cropchem Limited's Board of Directors, in a meeting held on May 13, 2026, recommended a final dividend of Rs. 9.00 per equity share for the financial year 2025-26. The dividend, on shares with a face value of Rs. 10.00 each, is subject to approval by shareholders at the forthcoming Annual General Meeting.

Consolidated Revenue ₹2,065 Cr vs ₹1,829 Cr (▲13% YoY), EBITDA ₹513 Cr vs ₹293 Cr (▲75% YoY), PAT ₹319 Cr vs ₹204 Cr (▲57% YoY). EBITDA Margin 24.8% vs 16.0% (▲880bps). The company also recommended a final dividend of ₹9 per equity share, bringing the total dividend for FY26 to ₹15 per share.

Sharda Cropchem Limited reported strong consolidated annual results for the year ended March 31, 2026. Consolidated Revenue from operations was ₹5,267.59 Cr vs ₹4,319.85 Cr (▲22% YoY). EBITDA stood at ₹1,181.77 Cr vs ₹655.11 Cr (▲80% YoY), and Net Profit (PAT) was ₹680.99 Cr vs ₹304.42 Cr (▲124% YoY). The EBITDA Margin expanded significantly to 22.43% from 15.16% (▲727bps). The Board also recommended a final dividend of Rs. 9.00 per equity share for FY26.

Sharda Cropchem Limited has scheduled a conference call for analysts and investors on Thursday, 14th May 2026, at 01:00 P.M. IST. The purpose of the call is to discuss the company's 4Q and FY26 earnings. Senior management, including the Chairman & Managing Director, CFO, and Company Secretary, will participate.

Sharda Cropchem Limited submitted the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026, regarding details of dematerialized/rematerialized securities.

Sharda Cropchem Limited announced the closure of its trading window from April 1st, 2026, until 48 hours after the Audited Financial Results for the quarter and financial year ended March 31st, 2026, are approved and filed with the Stock Exchanges. The Board meeting date will be informed in due course.

Sharda Cropchem Limited announced an Analyst/Institutional Investor Group Meeting on March 10, 2026, from 4:00 PM to 5:00 PM, organized by Arihant Capital. The virtual meeting will discuss publicly available information, with no unpublished price sensitive information intended to be shared.

Sharda Cropchem Limited's credit rating for short-term bank facilities of Rs. 456 crore has been reaffirmed at 'Crisil A1+' by Crisil Limited on February 23, 2026.

Transcript of the Q3 FY 2025-26 earnings call held on January 30, 2026. The company reported strong financial performance with 39% YoY revenue growth, 59% YoY EBITDA growth, and 366% YoY PAT growth, along with an interim dividend of ₹6 per share.

Sharda Cropchem Limited announced the availability of the audio recording for its Q3 FY 2025-26 earnings call with Analysts/Investors, conducted on January 30, 2026. A link to the recording is provided.